SECAUCUS, N.J., May 15, 2024
/PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in
diagnostic information services, today announced that its Board of
Directors declared a quarterly cash dividend of $0.75 per
share, payable on July 22, 2024 to shareholders of
record of Quest Diagnostics common stock on July 8,
2024.
About Quest Diagnostics
Quest Diagnostics works across
the healthcare ecosystem to create a healthier world, one life at a
time. We provide diagnostic insights from the results of our
laboratory testing to empower people, physicians and organizations
to take action to improve health outcomes. Derived from the world's
largest database of deidentified clinical lab results, Quest's
diagnostic insights reveal new avenues to identify and treat
disease, inspire healthy behaviors and improve healthcare
management. Quest Diagnostics annually serves one in three adult
Americans and half the physicians and hospitals in the United States, and our nearly 50,000
employees understand that, in the right hands and with the right
context, our diagnostic insights can inspire actions that transform
lives and create a healthier world.
www.QuestDiagnostics.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-declares-quarterly-cash-dividend-302146947.html
SOURCE Quest Diagnostics